Globus Medical Q2 net sales $745.3M (+18.4%); GAAP EPS $1.49, non-GAAP $0.86

GLOBUS MEDICAL INC

2025-Q2 EPS reported $2.01 revenue$1,343,463,000

Net sales $745.3M, up 18.4% YoY (17.6% constant currency); US Spine grew 5.7% as-reported.
GAAP net income $202.8M ($1.49 diluted EPS) vs $31.7M ($0.23) a year ago; includes $110.6M bargain purchase gain.
Non-GAAP diluted EPS $0.86 vs $0.75 (+14.1%); record quarterly non-GAAP EPS.
Full-year 2025 guidance reaffirmed: revenue $2.80-2.90B; non-GAAP EPS $3.00-3.30.
Closed Nevro acquisition; net cash from ops $77.9M, non-GAAP free cash flow $31.3M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.